Patent details

Basic Information

Publication number:

EP1121107

PCT Application Number:

PCT/IB/99/01571

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP999431687

PCT Publication Number:

WO/00/02152

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SERTRALINE ORAL CONCENTRATE

French Title of Invention:

CONCENTRE DE SERTRALINE PAR VOIE ORALE

German Title of Invention:

ORAL ANZUWENDENDES SERTRALINHALTIGES KONZENTRAT

SPC Number:

Dates

Filing date:

22/09/1999

Grant date:

19/11/2003

EP Publication Date:

19/11/2003

PCT Publication Date:

20/04/2000

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/08/2001

EP B1 Publication Date:

19/11/2003

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/09/2008

Expiration date:

22/09/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/09/1999

 

 

Name:

Pfizer Products Inc.

Address:

Eastern Point Road, Groton, Connecticut 06340, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

19/11/2003

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

WELCH Willard, McKowan

Address:

United States (US)

2

Name:

HARPER Nancy, Jane

Address:

United States (US)

3

Name:

RANADE Gautam, Ramchandra

Address:

United States (US)

Priority

Priority Number:

104024 P

Priority Date:

13/10/1998

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/135;

Filing date	Document type	Number of pages